insights_auto
Outlook: 31.6% bullish·21.1% bearish
Go to analysischevron_right
SYK:NYSE
Stryker Corp
$276.97
arrow_upward
+0.56%(+1.55) 1D
$272.63
arrow_downward
-1.57% (-4.34)bedtimeAfter hours
Closed: Oct 8, 4:01:09 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SYK...
Open
$275.72
High
$277.97
Low
$271.67
Mkt. cap
106.24B
Avg. vol.
2.89M
Volume
25.00
Dividend
1.27%
Quarterly dividend
$0.88
Ex-dividend date
Sep 30, 2026
P/E ratio
28.70
52-wk high
$392.55
52-wk low
$267.00
EPS
$9.65
Beta
0.77
Shares outstanding
383.57M
No. of employees
56K
Open
$275.72
High
$277.97
Low
$271.67
Mkt. cap
106.24B
Avg. vol.
2.89M
Volume
25.00
Dividend
1.27%
Quarterly dividend
$0.88
Ex-dividend date
Sep 30, 2026
P/E ratio
28.70
52-wk high
$392.55
52-wk low
$267.00
EPS
$9.65
Beta
0.77
Shares outstanding
383.57M
No. of employees
56K
News stories
From web sources and news partners
AD HOC NEWS
·
3 hours ago
EUR 245.95 at Lang & Schwarz: Stryker stock pre-market minus 0.36 percent versus the prior close
AD HOC NEWS
·
15 hours ago
Stryker stock sits at EUR 245.40 with USD 105.5 billion market cap
The Globe and Mail
·
18 hours ago
Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Stryker (SYK)
AD HOC NEWS
·
19 hours ago
Barclays upgrades Stryker stock to strong buy
Profile
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.
The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000. Wikipedia
About Stryker Corp
CEOKevin A. Lobo
Employees56K
Founded1941
HeadquartersKalamazoo, Michigan, United States
SectorMedical device
Websitestryker.com